Chemo Pharma Laboratories

136.65
+2.65
(1.98%)
ann
There are 2 new updates from the company1 day ago
Viewcross
right
Market Cap
20.50 Cr
EPS
-9.66
PE Ratio
51.54
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
154.00
52 Week Low
55.10
PB Ratio
1.47
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,803.90
#1 4,32,816.04
36.39
#1 49,887.20
12.06
#1 9,648
13.77
62.28
6,215.50
1,65,002.00
76.01
8,184.00
0.89
1,600
#1 64.53
65.97
1,551.70
1,25,317.61
24.82
26,520.70
14.17
4,155
47.38
63.02
3,325.10
1,12,536.49
60.60
10,785.70
11.59
1,656
13.54
62.35
2,599.20
1,07,237.41
51.44
10,615.60
19.57
1,942
-16.38
64.60
1,200.50
1,00,176.37
#1 18.42
28,905.40
12.36
5,578
1.69
61.75
2,104.10
96,060.78
33.25
20,141.50
#1 19.94
1,936
38.82
57.87
880.25
88,573.75
19.27
19,831.50
13.82
3,831
29.92
51.06
1,257.80
73,053.23
20.56
29,559.20
17.55
3,169
-10.04
65.79
30,060.00
63,875.40
48.47
6,097.20
10.80
1,201
16.01
49.09
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-101.57 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2016
TTM
Revenue
-1
0
Expenses
0
0
EBITDA
-1
0
Operating Profit %
0 %
0 %
Depreciation
0
0
Interest
0
0
Profit Before Tax
-1
0
Tax
0
0
Net Profit
-1
0
EPS in ₹
-9.66
0.00

Balance Sheet

Balance Sheet
2016
Total Assets
4
Fixed Assets
0
Current Assets
2
Capital Work in Progress
0
Investments
0
Other Assets
4
Total Liabilities
4
Current Liabilities
0
Non Current Liabilities
0
Total Equity
4
Reserve & Surplus
2
Share Capital
2

Cash Flow

Cash Flow
2016
Net Cash Flow
0
Investing Activities
2
Operating Activities
-2
Financing Activities
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.28 %
0.17 %
0.17 %
0.17 %
0.17 %
0.17 %
0.37 %
0.37 %
0.37 %
0.17 %
0.37 %
0.17 %
0.37 %
0.37 %
0.37 %
0.37 %
0.37 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
65.76 %
65.77 %
65.51 %
65.70 %
65.74 %
65.72 %
65.57 %
65.38 %
65.40 %
65.56 %
65.55 %
65.51 %
65.61 %
65.63 %
65.60 %
65.50 %
65.29 %
Others
6.07 %
6.17 %
6.44 %
6.25 %
6.21 %
6.22 %
6.18 %
6.37 %
6.35 %
6.39 %
6.19 %
6.44 %
6.14 %
6.12 %
6.15 %
6.25 %
6.46 %
No of Share Holders
5,949
6,082
6,129
6,213
6,225
6,226
6,226
6,274
6,289
6,268
6,275
6,254
6,262
6,254
6,382
6,576
6,510

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Change in Management1 day ago
Announcement under Regulation 30 (LODR)-Change in Management1 day ago
Announcement under Regulation 30 (LODR)-Change in Management8 days ago
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD ON WEDNESDAY APRIL 16 20258 days ago
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A8 days ago
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A9 days ago
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation 20159 days ago
Board Meeting Intimation for Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure Requirement) Regulations 2015 Board Meeting To Be Held On Wednesday April 16 2025Apr 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 02, 2025
Closure of Trading WindowMar 31, 2025
Draft Letter of OfferFeb 28, 2025
Draft Letter of OfferFeb 28, 2025
Detailed Public StatementFeb 24, 2025
Intimation Of Signing Of Share Purchase Agreement (SPA) Between The Promoter & Promoter Group And AcquirerFeb 18, 2025
Submission Of Public Announcement To The Public Shareholders Of M/S Chemo Pharma Laboratories LimitedFeb 18, 2025
Public Announcement - Open OfferFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 28, 2025
Integrated Filing (Financial)Jan 27, 2025
Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday January 27 2025Jan 27, 2025
Board Meeting Intimation for Board Meeting To Be Held On Monday January 27 2025Jan 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 31, 2024
Closure of Trading WindowDec 31, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 29, 2024
Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 28, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, October 28, 2024Oct 28, 2024
Board Meeting Intimation for Board Meeting To Be Held On Monday, October 28, 2024Oct 15, 2024
Reply To The Clarification Sought On Movement In Price Of The Shares Across Exchanges Of Shares Of The CompanyOct 14, 2024
Clarification sought from Chemo Pharma Laboratories LtdOct 11, 2024
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015Oct 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 01, 2024
Closure of Trading WindowSep 30, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 24, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 02, 2024
Reg. 34 (1) Annual Report.Aug 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2024
Intimation Of Book Closure And Record Date For The Annual General Meeting To Be Held For The Financial Year 2023-2024Jul 29, 2024
Submission Of Un-Audited Financial Results For The Quarter Ended June 30, 2024Jul 29, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, July 29, 2024Jul 29, 2024
Board Meeting Intimation for Board Meeting To Be Held On Monday, July 29, 2024Jul 09, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 02, 2024
Closure of Trading WindowJun 28, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJun 10, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2024
Appointment Of M/S. Sarda Soni Associates LLP As An Internal Auditor For The Financial Year 2024-2025May 27, 2024
Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024May 27, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, May 27, 2024May 27, 2024

Technical Indicators

RSI(14)
Neutral
75.17
ATR(14)
Less Volatile
3.11
STOCH(9,6)
Overbought
81.26
STOCH RSI(14)
Neutral
26.97
MACD(12,26)
Bearish
-0.39
ADX(14)
Very Strong Trend
53.57
UO(9)
Bearish
71.85
ROC(12)
Uptrend And Accelerating
3.41
WillR(14)
Overbought
-0.29